Tulane University School of Medicine, New Orleans, LA, USA.
Curr Cardiol Rep. 2023 Oct;25(10):1319-1326. doi: 10.1007/s11886-023-01947-x. Epub 2023 Sep 2.
This review aims to describe recent literature, guidelines, and approaches to reveal and reduce hypertension burden in disadvantaged populations. Hypertension is a major global health issue and the most potent risk factor for cardiovascular disease, morbidity, and mortality. It disproportionally affects vulnerable populations, including low-, middle-, and high-income countries. Specifically, the burden of hypertension is higher in US Black adults, and addressing social determinants of health is crucial for reducing disparities among vulnerable populations worldwide.
Multifactorial approaches, including lifestyle modifications and combination drug therapy, are essential in managing hypertension. Community-based interventions, team-based care, and telehealth strategies can also improve hypertension control. Additionally, renal nerve denervation is a potential treatment for resistant hypertension. Overall, to reduce the global hypertension burden among vulnerable populations, emphasis should be placed on equitable healthcare access and application of evidence-based medicine.
本综述旨在描述最近的文献、指南和方法,以揭示和减轻弱势人群的高血压负担。高血压是一个全球性的主要健康问题,也是心血管疾病发病率和死亡率的最主要危险因素。它不成比例地影响弱势群体,包括低收入、中等收入和高收入国家。具体来说,美国黑人成年人的高血压负担更高,解决健康的社会决定因素对于减少全球弱势群体之间的差距至关重要。
多因素方法,包括生活方式的改变和联合药物治疗,对于高血压的管理至关重要。基于社区的干预、团队护理和远程医疗策略也可以改善高血压的控制。此外,肾神经去神经支配是治疗难治性高血压的一种潜在方法。总的来说,为了降低全球弱势群体的高血压负担,应重视公平获得医疗保健和应用基于证据的医学。